Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders

Yossi Rosman*, Noa Lavi, Keren Meir-Shafrir, Idit Lachover-Roth, Anat Cohen-Engler, Yoseph A. Mekori, Ronit Confino-Cohen

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations
Original languageEnglish
Pages (from-to)3487-3489
Number of pages3
JournalJournal of Allergy and Clinical Immunology: In Practice
Volume9
Issue number9
DOIs
StatePublished - Sep 2021

Cite this